ZURICH/BERLIN, Oct 8(Reuters) - The Swiss blue-chip SMI .SSMI was seen opening unchanged at 9,916 points on Tuesday, according to premarket indications by bank Julius Baer JBPRE01 .
Here are some of the main factors that may affect Swiss stocks on Tuesday:
NOVARTIS NOVN.S
The company said it has received approval from the U.S. Food and Drug Administration for its Beovu drug to treat a cause of vision loss. more news, click on NOVN.S
ARYZTA ARYN.S
The frozen baked goods maker said it expects underlying core earnings growth to improve in 2020, as it sees the benefits of the cost-and-debt cutting program kicking in and the North American business stabilising. more news, click on ARYN.S
COMPANY STATEMENTS E-CH
* Australian graphite explorer Talga Resources Ltd TLG.AX said it had executed an MOU with Switzerland-based battery maker Leclanché Sa LECN.S and that under the MOU, Leclanché will evaluate the company's range of Swedish anode products.
* Autoneum AUTON.S said it has appointed Matthias Holzammer as CEO with immediate effect. AUTON.S
ANALYSTS' VIEWS
* SIKA AG SIKA.S : Jefferies cuts target price to CHF 189.40 from CHF 192
* KUEHNE UND NAGEL INTERNATIONAL KNIN.S : JP Morgan starts with overweight
* ABB ABBN.S : Citigroup (NYSE:C) cuts its target price to 26 Swiss francs from 27 francs previously.
ECONOMY M-CH
The Swiss unemployment rate remained steady at 2.1% in September compared to August in non-seasonally adjusted terms, the State Secretariat for Economic Affairs said.